Kimberly R. Southern

Chief Executive Officer at Glauconix Biosciences, Inc.

Electronic Technology

Commercial Services

Profile

Kimberly R.
Southern has held the following positions in her career: Chief Executive Officer at Glauconix Biosciences, Inc. since 2019, and President at QuadTech, Inc.

Kimberly R. Southern active positions

Companies	Position	Start
QuadTech, Inc. QuadTech, Inc. Electronic Equipment/InstrumentsElectronic Technology QuadTech, Inc. manufactures test control products. The company is headquartered in Marlborough, MA.	President	-
Glauconix Biosciences, Inc. Glauconix Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Glauconix Biosciences, Inc. is a company that specializes in developing ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery. The company is based in Albany, NY. The company's 3D tissue models can de-risk ophthalmic assets and expedite drug development, adding value to their clients and partners by expediting early identification and validation of effective compounds or biologics in the preclinical phase and those entering clinical trials. The company was founded in 2014 by Karen Torrejon, Feryan Ahmed. Kimberly R. Southern has been the CEO of the company since 2019.	Chief Executive Officer	01/12/2019

All active positions of Kimberly R. Southern

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kimberly R. Southern's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
QuadTech, Inc. QuadTech, Inc. Electronic Equipment/InstrumentsElectronic Technology QuadTech, Inc. manufactures test control products. The company is headquartered in Marlborough, MA.	Electronic Technology
Glauconix Biosciences, Inc. Glauconix Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Glauconix Biosciences, Inc. is a company that specializes in developing ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery. The company is based in Albany, NY. The company's 3D tissue models can de-risk ophthalmic assets and expedite drug development, adding value to their clients and partners by expediting early identification and validation of effective compounds or biologics in the preclinical phase and those entering clinical trials. The company was founded in 2014 by Karen Torrejon, Feryan Ahmed. Kimberly R. Southern has been the CEO of the company since 2019.	Commercial Services